Development and Validation of a Nomogram of Predict Eligibility for Second-line Chemotherapy in Pancreatic Cancer
Anticancer Research · 2025
DOI: 10.21873/anticanres.17798 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Anticancer Research, 2025. Verfasst von Kentaro Sato und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima, Japan. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Nomograms, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima, Japan.
- Department of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima, Japan; subaru@fmu.ac.jp.
- Department of Gastroenterology, Fukushima Red Cross Hospital, Fukushima, Japan.
- Department of Gastroenterology, Ohara General Hospital, Fukushima, Japan.
- Department of Gastroenterology, Iwase General Hospital, Fukushima, Japan.
- Department of Gastroenterology, Soma General Hospital, Fukushima, Japan.
Zitieren
APA
Sato, K., Suzuki, R., Konno, N., Irie, H., Watanabe, K. O., Imaizumi, H., Waragai, Y., Sugimoto, M., Asama, H., Shimizu, H., Ohira, R., & Ohira, H. (2025). Development and Validation of a Nomogram of Predict Eligibility for Second-line Chemotherapy in Pancreatic Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.17798
Vancouver
Sato K, Suzuki R, Konno N, Irie H, Watanabe KO, Imaizumi H, et al. Development and Validation of a Nomogram of Predict Eligibility for Second-line Chemotherapy in Pancreatic Cancer. Anticancer Research. 2025. doi:10.21873/anticanres.17798
BibTeX
@article{Sato2025,
author = {Sato, Kentaro and Suzuki, Rei and Konno, Naoki and Irie, Hiroki and Watanabe, K O and Imaizumi, Hiromichi and Waragai, Yuichi and Sugimoto, Mitsuru and Asama, Hiroyuki and Shimizu, Hiroshi and Ohira, Rei and Ohira, Hiromasa},
title = {Development and Validation of a Nomogram of Predict Eligibility for Second-line Chemotherapy in Pancreatic Cancer},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17798}
}
EUVIMED